-
Yuji Nakamura
Department of Pharmacology, Faculty of Medicine, Toho University, Japan
-
Junko Matsuo
Department of Pharmacology, Faculty of Medicine, Toho University, Japan Division of Pharmacology, National Institute of Health Sciences, Japan Drug Safety Research Laboratories, Shin Nippon Biomedical Laboratories, Ltd., Japan
-
Norimasa Miyamoto
Biopharmaceutical Assessments Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., Japan
-
Atsuko Ojima
Biopharmaceutical Assessments Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., Japan
-
Kentaro Ando
Department of Pharmacology, Faculty of Medicine, Toho University, Japan
-
Yasunari Kanda
Division of Pharmacology, National Institute of Health Sciences, Japan
-
Kohei Sawada
Biopharmaceutical Assessments Core Function Unit, Eisai Product Creation Systems, Eisai Co., Ltd., Japan
-
Atsushi Sugiyama
Department of Pharmacology, Faculty of Medicine, Toho University, Japan
-
Yuko Sekino
Division of Pharmacology, National Institute of Health Sciences, Japan Department of Neurobiology and Behavior, Gunma University Graduate School of Medicine, Japan